Core Viewpoint - Vitasoy reported a revenue of HKD 6.274 billion for the fiscal year ending March 31, 2025, reflecting a 1% year-on-year growth, while net profit attributable to shareholders surged by 102% to HKD 235 million, driven by improved sales execution in mainland China and strong performance in Hong Kong [1][2] Group 1: Financial Performance - Revenue growth of 1% in FY2025 was primarily due to growth in core products in mainland China and stable performance in Hong Kong [1] - Net profit doubled due to cost reduction and efficiency improvement measures, with operating profit in mainland China increasing by 41% and in Hong Kong by 24% [1] Group 2: Market Dynamics - The mainland market is Vitasoy's main revenue source, facing intense competition and rising consumer price sensitivity, leading to a previous price reduction strategy [1][2] - Vitasoy's management announced that there will be no further price reductions in the mainland market, indicating that the pricing of their lemon tea is already competitive after a 10%-15% price cut in the previous half-year [2][3] Group 3: Product Strategy - Vitasoy aims to maintain market advantage through high-quality products and services rather than relying solely on price competition [3] - The company has adjusted its product mix to be more economical and competitive, particularly in the tea beverage segment [3][5] Group 4: Industry Trends - The beverage industry in China is experiencing a shift, with a reported production of 188 million tons in 2024, a 7.5% increase year-on-year, and total revenue of CNY 534.8 billion, up 4.8% [7] - The plant-based beverage market is facing a slowdown, but Vitasoy believes in its long-term potential due to low per capita consumption compared to global averages and significant growth opportunities in lower-tier cities [7][8] Group 5: Competitive Landscape - The tea beverage market is growing, with increasing consumer demand for health-oriented and diverse product offerings [8] - Vitasoy has been expanding its low-sugar and no-sugar beverage options since 2015/16, but faces challenges from increased competition in the no-sugar tea segment [8][9]

Annual Results FY2024/25 24 June 2025 FINANCIAL REVIEW Ian Ng Group CFO Disclaimer In addition to historical information, this presentation contains forward-looking statements with respect to the results of the operations and business of Vitasoy. These forward-looking statements represent Vitasoy's expectations or beliefs concerning future events and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied i ...

Group 1 - The core viewpoint of the article highlights Vitasoy International's revenue growth of 1% for the fiscal year 2024/2025, reaching HKD 6.274 billion, driven by strong performance in core products in mainland China and stable results in Hong Kong [1] - The company's net profit attributable to equity holders surged by 102% to HKD 235 million, attributed to improved sales execution in mainland China and strong performance in Hong Kong [1] - The company plans to distribute a final dividend of HKD 0.102 per share, pending approval at the annual general meeting on August 25, 2025, resulting in a total dividend of HKD 0.142 per share for the fiscal year 2024/2025, compared to HKD 0.077 per share in the previous fiscal year [1] Group 2 - Vitasoy International aims to maintain business scale and profitability across all operating units while focusing on expanding market share in core products like plant-based milk and ready-to-drink tea, particularly in mainland China [2] - The company acknowledges challenges from a worsening external environment and slowing growth in various product categories but remains confident in its core product portfolio and health innovation series to capture growth opportunities [2]

Financial Performance Overview - Group revenue increased by 1% for the full year, with a gross profit margin improvement of 1.3 percentage points to 51.3% [6][30] - Profit from operations grew substantially by 9622%, and profit attributable to equity shareholders increased by 102% to HKD235 million [7][30] - EBITDA increased by 29% year on year, driven by higher gross profit contribution and effective operating cost rationalization [5][30] - Cash on hand was HKD1.27 billion, with a net cash position of HKD657 million and a gearing ratio decreased to 20% [8] Business Line Performance - Mainland China revenue grew by 2% in the second half, contributing to a full-year growth of 1% amid intensified market competition [12][15] - Operating profit in Mainland China increased by 41%, achieving a 9% operating margin [19] - Hong Kong's operating profit grew by 24%, with a 12% operating profit margin, driven by higher sales volumes and favorable commodity costs [23] - Australia saw a revenue growth of 5% in local currency, with a narrowed operating loss by more than 30% in local currency terms [24] Market Performance - Mainland China remains the largest market, accounting for 54% of group revenue [15] - Singapore experienced a slight revenue decrease, but growth in the export tofu business helped offset some softness in beverage sales [25] - The Philippines joint venture with Universal Robina Corporation continued to drive scale and market share growth [25] Company Strategy and Industry Competition - The company will prioritize sustaining business scale and profitability amid geopolitical and economic challenges [14][30] - Focus on maintaining structural profitability in Mainland China while solidifying core portfolio in Hong Kong [14] - Plans to improve field sales execution and increase portfolio innovation to enhance value competitiveness [20] Management Commentary on Operating Environment and Future Outlook - Management expressed confidence in gradual improvement and long-term prospects despite short-term macro challenges [15][30] - The company aims to leverage local sourcing and manufacturing to mitigate international tariff risks [14] - Emphasis on enhancing energy efficiency and sustainable practices as part of the long-term strategy [29] Other Important Information - The company announced an updated sustainability framework with ambitious goals for reducing sugar content in products [28][29] - The eleventh annual sustainability report will be available in July, highlighting progress on sustainability targets [26] Q&A Session Summary Question: What are the expectations for growth in Mainland China? - Management indicated that sales growth must come from market share due to significant competitive pricing pressure [19] Question: How is the company addressing the competitive environment in Australia? - The company is implementing commercial programs to improve brand presence and impact across grocery and coffee channels [24] Question: What are the sustainability goals moving forward? - The company aims for 80% of its portfolio to be low sugar or no added sugar products by 2030, reflecting a stronger focus on health trends [28]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任 何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （於香港註冊成立之有限公司） （股份代號：345） 建議修訂本公司章程細則 本公告乃維他奶國際集團有限公司（「本公司」）根據香港聯合交易所有限公 司證券上市規則（「上市規則」）第 13.51(1)條作出。 於本公告日，羅友禮先生、陸博濤先生及黎中山先生為執行董事。羅慕玲女士、 羅德承先生及羅其美女士為非執行董事。黎定基先生、 Paul Jeremy BROUGH 先生、鍾志平博士及容韻儀女士為獨立非執行董事。 一份載有（其中包括）建議修訂詳情之通函及召開股東週年大會的通告，將適 時地寄發予本公司股東。 承董事會命 維他奶國際集團有限公司 執行主席 羅友禮 香港，二零二五年六月二十四日 董事（「董事」）會（「董事會」）建議對本公司現有章程細則（「章程細 則」）進行若干修訂（「建議修訂」），旨在使章程細則符合：(i) 最近修訂 的《公司條例》有關允許在香港註冊成立的上市公司實施庫存股份制度以及推 動以無紙化 ...

EF001 發行人所發行上市權證/可轉換債券的相關信息 發行人所發行上市權證/可轉換債券 不適用 其他信息 其他信息 不適用 發行人董事 羅友禮先生、陸博濤先生及黎中山先生為執行董事。羅慕玲女士、羅德承先生及羅其美女士為非執行董事。黎定基先生、Paul Jeremy BROUGH先生、鍾志平博士及容韻儀女士為獨立非執行董事。 EF001 第 2 頁 共 2 頁 v 1.1.1 免責聲明 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 | | | --- | --- | | 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | 股票發行人現金股息公告 | | | 發行人名稱 | 維他奶國際集團有限公司 | | 股份代號 | 00345 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 | 截至二零二五年三月三十一日止年度之末期股息 | | 公告日期 | 2025年6月24日 | | 公告狀態 | 新公告 | | 股息信息 | | | 股息類型 ...

Financial Performance - Revenue for the fiscal year ended March 31, 2025, increased by 1% to HKD 6,274 million compared to HKD 6,217 million in the previous year[3]. - Gross profit rose by 3% to HKD 3,218 million, with a gross margin improvement from 50.0% to 51.3%[3][5]. - Operating profit surged by 96% to HKD 364 million, while net profit attributable to equity holders increased by 102% to HKD 235 million[3][5]. - The overall comprehensive income for the year was HKD 222 million, significantly higher than HKD 13 million in the previous year[7]. - Profit before tax increased by 141% to HKD 317,000,000, up from HKD 132,000,000 in the previous fiscal year[44]. - The company's profit attributable to equity holders was HKD 235,000,000, a 102% increase from HKD 116,000,000 in the previous fiscal year[46]. - EBITDA for the year was HKD 836,000,000, an increase of 22% year-on-year, driven by higher gross profit contributions and effective cost control[47]. - The profit margin of EBITDA increased from 11% to 13%[47]. Dividends - The board proposed a final dividend of HKD 0.102 per share, bringing the total dividend for the fiscal year to HKD 0.142 per share, up from HKD 0.077 in the previous year[5]. - The proposed final dividend for 2025 is HKD 10.2 cents per share, up from HKD 6.3 cents per share in 2024, representing a growth of approximately 62.9%[24]. - The company has declared an interim dividend of HKD 4.0 cents per share for 2025, significantly higher than HKD 1.4 cents per share in 2024, marking an increase of 185.7%[24]. Assets and Liabilities - Total assets decreased from HKD 3,389,625 thousand in 2024 to HKD 3,023,166 thousand in 2025, a decline of approximately 10.8%[8]. - Current assets increased from HKD 2,247,070 thousand in 2024 to HKD 2,625,534 thousand in 2025, representing an increase of about 16.8%[8]. - Net current assets improved significantly from HKD 21,694 thousand in 2024 to HKD 483,549 thousand in 2025, a substantial increase of approximately 2,130%[9]. - Non-current liabilities decreased from HKD 298,682 thousand in 2024 to HKD 324,533 thousand in 2025, an increase of about 8.7%[9]. - Total equity increased from HKD 3,112,637 thousand in 2024 to HKD 3,182,182 thousand in 2025, reflecting a growth of approximately 2.2%[9]. - The company's total liabilities decreased from HKD 2,225,376 thousand in 2024 to HKD 2,141,985 thousand in 2025, a reduction of about 3.8%[8]. - Total liabilities for 2025 decreased to HKD 3,102,639,000 from HKD 3,442,395,000 in 2024, reflecting a reduction of about 9.85%[17]. Cash Flow and Financing - Cash and bank deposits (excluding bank loans) increased significantly from HKD 538 million to HKD 1,003 million[5]. - Cash and bank deposits rose significantly from HKD 794,452 thousand in 2024 to HKD 1,268,475 thousand in 2025, an increase of about 59.7%[8]. - The group's net cash position (cash and bank deposits minus bank borrowings, notes payable, and lease liabilities) was HKD 657,000,000, up from HKD 111,000,000 a year earlier[64]. - The total debt of the group was HKD 610,000,000, a decrease from HKD 684,000,000 as of March 31, 2024[64]. - The debt-to-equity ratio decreased to 20% from 23% year-over-year, and the ratio excluding lease liabilities was 10%, down from 13%[64]. - The company received government grants totaling HKD 5,298,000 in 2025, a decrease from HKD 30,818,000 in 2024[18]. Operational Highlights - Operating profit margin for the mainland China business improved to 9%, with a 41% increase in operating profit[5]. - The Hong Kong business achieved a 24% increase in operating profit, with an operating profit margin of 12%[5]. - The company experienced a strong recovery in its tofu business in Singapore, transitioning to a new distributor for imported beverages[5]. - The company experienced a significant increase in sales in mainland China during the second half of the fiscal year, contributing to overall sales growth despite challenges in the local retail market[38]. - The company noted a shift in consumer behavior towards price sensitivity, which may pose short-term challenges in the upcoming fiscal year[38]. - The company has established a joint venture in the Philippines with Universal Robina Corporation, which has driven strong revenue growth through convenience store platforms[38]. - The company plans to enhance sales strategies and product innovation to support its core brands in the upcoming fiscal years[60]. - A joint venture with Universal Robina Corporation will continue to expand in the promising market and drive growth in the plant-based milk sector[61]. Share Repurchase - The company repurchased a total of 4,232,000 shares at a total cost of HKD 40 million during the fiscal year[5]. - The company purchased 1,300,000 shares for approximately HKD 7,600,000 as part of its 2021 share incentive plan[72]. Governance and Compliance - The company maintains a high level of corporate governance and complies with the corporate governance code as of March 31, 2025[68].

Group 1 - The generational shift in the consumer market is reshaping the survival logic of traditional categories, with Vitasoy's launch of White Peach Soy Milk responding to this trend by transforming traditional soy milk into a youthful consumer product [1] - Vitasoy's core advantage lies in the dual value of "nutrition + emotion," combining the recognized plant protein attributes of soy milk with the introduction of the white peach flavor, catering to the preferences of the younger generation [3] - The launch of White Peach Soy Milk marks Vitasoy's upgrade from a single nutritional carrier to a composite product, expanding its product line and appealing to a broader consumer base beyond traditional breakfast scenarios [3] Group 2 - To support the launch of White Peach Soy Milk, Vitasoy organized a marketing campaign that integrated the product into everyday leisure scenarios, effectively targeting the student demographic in Guangzhou [4] - The strategy of combining offline leisure scenarios with purchasing behavior enhances consumer experience and strengthens the brand's connection with younger consumers [4] - The success of Vitasoy's White Peach Soy Milk demonstrates the potential for rejuvenating traditional categories by merging nutritional needs with emotional value, indicating a significant direction for the future of the food and beverage industry [4]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公 告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責任。 （於香港註冊成立之有限公司） （股份代號：345） 董事會召開日期 維他奶國際集團有限公司(「本公司」)之董事會(「董事會」)宣佈，本公司 將於二零二五年六月二十四日(星期二)舉行董事會會議，藉以(其中包括)批 准截至二零二五年三月三十一日止之全年業績及考慮派發末期股息(如有)。 代表董事會 維他奶國際集團有限公司 公司秘書 蘇漪筠 香港，二零二五年六月十一日 於本公告日，羅友禮先生、陸博濤先生及 黎中山先生為執行董事。 羅慕玲女士、羅德承先生及羅其美女士為非執行董事。黎定基先生、 Paul Jeremy BROUGH 先生、鍾志平博士及容韻儀女士為獨立非執行董事。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任 何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （於香港註冊成立之有限公司） （股份代號：345） 盈利預告 本公告乃由維他奶國際集團有限公司（「本公司」，連同其附屬公司統稱 為「本集團」）根據香港聯合交易所有限公司證券上市規則（「上市規 則」）第 13.09 條及中華人民共和國香港特別行政區（「香港特別行政區」） 法例第 571 章證券及期貨條例第 XIVA 部項下之內幕消息條文（定義見上市 規則）而作出。 1 本盈利預告公告僅根據董事會參考管理層估算後作出的初步評估，並考慮 了本集團現有資料，其中包括本財政年度的未經審核綜合管理賬目而作 出，且尚未經本公司審核委員會或核數師審閱或審核及可能作出調整。本 公司正在完成編制本財政年度之全年業績。敬請股東及潛在投資者細閱本 公司預期於二零二五年六月底前公佈之本財政年度之全年業績公告。 股東及潛在投資者於買賣本公司股份時務請審慎行事。 本公司董事會（「董事會」）謹此通知本公司股東（「股東」）及潛在投 資者 ...